Stockscreener 앱 받기
3.92
4.16%
-0.17
시간 외 거래:
3.93
0.01
+0.26%
Relay Therapeutics Inc 주식(RLAY)의 최신 뉴스
Savant Capital LLC Buys Shares of 29,088 Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics (RLAY) Projected to Post Quarterly Earnings on Thursday - Defense World
The Potential Rise in the Price of Relay Therapeutics Inc (RLAY) following insiders activity - Knox Daily
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq
Relay Therapeutics to Announce Fourth Quarter and Full Year - GlobeNewswire
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and ... - The Bakersfield Californian
This Insider Has Just Sold Shares In Relay Therapeutics - Simply Wall St
Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock - MSN
Relay Therapeutics (NASDAQ:RLAY) Shares Gap DownTime to Sell? - MarketBeat
Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sanjiv Patel Sells 75,324 Shares - MarketBeat
Insider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sells 140,182 Shares of Stock - MarketBeat
Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock By Investing.com - Investing.com Australia
Relay Therapeutics: A Precision Oncology Play Worth The Risk - Seeking Alpha
Q2 Earnings Forecast for RLAY Issued By Leerink Partnrs - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down – Should You Sell? - Defense World
Q2 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World
Quarterly Metrics: Quick and Current Ratios for Relay Therapeutics Inc (RLAY) - The Dwinnex
Brokers Issue Forecasts for RLAY Q1 Earnings - Defense World
RLAY’s Market Whiplash: 9.47% YTD Rise, -1.31% Plunge in 30 Days - The InvestChronicle
Analysts Set Expectations for RLAY Q1 Earnings - Armenian Reporter
Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - SETE News
BlackRock, Inc. Expands Stake in Relay Therapeutics Inc with Sig - GuruFocus.com
Jefferies Upgrades Relay Therapeutics Inc (RLAY) to a Buy from a Hold - Knox Daily
SG Americas Securities LLC Grows Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Brokerages - ETF Daily News
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
How should investors view Relay Therapeutics Inc (RLAY)? - US Post News
Is Relay Therapeutics Inc (NASDAQ: RLAY) Stock Worth Investing In for High Returns? - Marketing Sentinel
Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Peter Rahmer Sells 17,250 Shares - MarketBeat
Relay Therapeutics, Inc. (NASDAQ:RLAY) CFO Thomas Catinazzo Sells 20,791 Shares - MarketBeat
Insider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) CFO Sells 36,036 Shares of Stock - MarketBeat
Relay Therapeutics Insider Sold Shares Worth $268,339, According to a Recent SEC Filing - Marketscreener.com
Relay Therapeutics Inc (RLAY) Forecast: Revisiting The Past To Gain Insights For The Future - Stocks Register
Winning over Wall Street: Biotechs’ comeback playbook — a Guest Commentary by Jami Rubin - BioCentury
Relay Therapeutics CEO Sanjiv Patel sells $1.76 million in stock - MSN
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down on Insider Selling - Defense World
Insider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sells $600,000.00 in Stock - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Shares Down 6%Here's What Happened - MarketBeat
Relay Therapeutics Inc (RLAY): AI-Driven Cancer Treatments Backed by Barclays’ $17 Price Target - MSN
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down After Insider Selling - MarketBeat
Relay Therapeutics CEO Sanjiv Patel sells $1.76 million in stock By Investing.com - Investing.com UK
Relay Therapeutics (NASDAQ:RLAY) Trading 6.8% HigherHere's Why - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Sets New 52-Week LowShould You Sell? - MarketBeat
0.27%
3.05%
자본화:
|
볼륨(24시간):